New to Meducation?
Sign up
Already signed up?
Log In
Add To Boards
Add
Upvote
0
CPD Tracker
00:00
FDA OKs Osimertinib for Specific Non-Small-Cell Lung Cancers
A new drug is available for patients with non-small-cell lung cancer (NSCLC) who progress on epidermal growth-factor receptor inhibitors and who have a specific related mutation.
#Oncology
x
#Respiratory
x
#MedicalOncology
x
#PulmonaryMedicine
x
#LungNeoplasms
x
#Cells
x
#Mutation
x
Help by adding tags...
Lung Cancer | Doctor | Patient
- The management guidelines for small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC) in this article are taken from the guidelines published...
1
19
Trending
Endocrine System Chart
- Useful chart explaining glands and hormones!
101
14874
Dual therapy's 1-2 punch knocks out drug-resistant lung cancer
- Unusual chance to study patient's residual tumor leads to new findingCapitalizing on a rare opportunity to thoroughly analyze a tumor from a lung cancer patient who had...
0
19
EGFR Testing Not Done in 25% of Lung Cancer Patients
- Not all patients with advanced NSCLC undergo testing for the EGFR mutation, and for some patients who do undergo testing, therapy is initiated before the results are received.
0
14
Lung Cancer Explained Clearly
- Comparison of the main types of lung cancers: squamous, adenocarcinoma, large cell, and small cell lung cancer.
4
142
Cranial Nerves - Anatomy, Clinical Signs and Study Tips
- This is a teaching resource that aids the student in memorisation of the Cranial Nerves, their anatomical path and function. Additionally, it stimulates a clinical approach to the functions of t...
1187
40270
